Drug interactions between lenalidomide and panobinostat
| Results for the following 2 drugs: |
|---|
| lenalidomide |
| panobinostat |
Interactions between your drugs
There were no interactions found in our database between lenalidomide and panobinostat - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
lenalidomide
A total of 225 drugs are known to interact with lenalidomide.
- Lenalidomide is in the following drug classes: miscellaneous antineoplastics, other immunosuppressants.
- Lenalidomide is used to treat the following conditions:
panobinostat
A total of 861 drugs are known to interact with panobinostat.
- Panobinostat is a member of the drug class histone deacetylase inhibitors.
- Panobinostat is used to treat Multiple Myeloma.
Drug and food interactions
panobinostat food
Applies to: panobinostat
Do not consume grapefruit, grapefruit juice, star fruit, pomegranate, or pomegranate juice during treatment with panobinostat. Doing so can increase blood levels of the medication. You may be more likely to experience side effects such as nausea; vomiting; diarrhea; loss of appetite; fatigue; swelling in the arms or legs; heart problems (e.G., chest pain, heart failure, irregular heartbeat); liver problems; and impaired bone marrow function resulting in low numbers of different types of blood cells, which can increase the risk of anemia, bleeding problems, and infections. Talk to your doctor if you have any questions or concerns. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See Also
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No information available. |
Do not stop taking any medications without consulting your healthcare provider.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
